Showing results (1051-1060 of 1,176) with videos related to
Sort By:
Pageof 118
Cancer Cytopathology|August 24, 2017
A pattern-based risk-stratification scheme for salivary gland cytology: A multi-institutional, interobserver variability study to determine applicabilityChristopher C Griffith, Alessandra C Schmitt, Liron Pantanowitz, et al.Cancer Cytopathology|May 20, 2022
Cytopathology of solid pancreatic neoplasms: An algorithmic approach to diagnosisQun Wang, Michelle D ReidCancer Cytopathology|January 4, 2020
Breast implant-associated anaplastic large cell lymphoma and effusions: A review with emphasis on the role of cytopathologyLouis-André Julien, René P Michel, Manon AugerCancer Cytopathology|April 4, 2020
Racial differences in HPV type 16 prevalence in women with ASCUS of the uterine cervixCarolann Risley, Megan A Clarke, Kim R Geisinger, et al.Cancer Cytopathology|September 25, 2020
Programmed death-ligand 1 (PD-L1)/thyroid transcription factor-1 double immunohistochemical staining facilitates scoring of tumor PD-L1 expression in cytopathology specimens from lung adenocarcinoma patientsYen-Yu Lin, Li-Ya Lin, Jen-Fan Hang, et al.Cancer Cytopathology|September 30, 2020
Evaluation of circulating tumor cell clusters for pan-cancer noninvasive diagnostic triagingAndrew Gaya, Timothy Crook, Nicholas Plowman, et al.Cancer Cytopathology|January 25, 2021
Cytologic and histological features of rare nonepithelial and nonlymphoid tumors of the thyroidEsther Diana Rossi, Liron Pantanowitz, Jason L HornickCancer Cytopathology|January 19, 2021
Diagnostic mesothelioma biomarkers in effusion cytologyAlbino Eccher, Ilaria Girolami, Ersilia Lucenteforte, et al.Cancer Cytopathology|November 15, 2021
Serial FNA allows direct sampling of malignant and infiltrating immune cells in patients with B-cell lymphoma receiving immunotherapyKelly L Mooney, Debra K Czerwinski, Tanaya Shree, et al.Cancer Cytopathology|October 20, 2022
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk groupFrancesco Pierconti, Esther Diana Rossi, Tonia Cenci, et al.Pageof 118